Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control

Li Sun; Xia Wei; Ranjit Manchanda; Rosa Legood; Li Yang

doi:10.46234/ccdcw2022.148

Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control

China CDC Wkly. 2022 Aug 12;4(32):711-714. doi: 10.46234/ccdcw2022.148.

Authors

Li Sun^{1

2}, Xia Wei^{1

2}, Ranjit Manchanda^{1

2

3}, Rosa Legood¹, Li Yang⁴

Affiliations

¹ Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
² Wolfson Institute of Population Health, Barts CRUK Cancer Centre, Queen Mary University of London, London, UK.
³ Department of Gynaecological Oncology, Barts Health NHS Trust, London, UK.
⁴ School of Public Health, Peking University, Beijing, China.

No abstract available

Keywords: Breast Cancer; Cancer Diagnosis; Cost-effectiveness; Genetic Testing.

Grants and funding

China Medical Board (Grant No.19-336), the National Natural Science Foundation of China (Grant No. 71911530221 and 72174010) and the National Key Research and Development Program of China (Grant No. 2021YFC2500405)